Table 3.
Domain | No. | RCD | Ratio* | No. | CD | Ratio* |
---|---|---|---|---|---|---|
N | 25 | EKDKGLQTSQ | 7/12 | |||
27 | GLQTSQDARF | 9/14 | ||||
34 | ASFAEAPFSN | 10/14 | ||||
35 | FAEAPFSNKG | 8/14 | ||||
51 | KLFPNSLDQT | 7/12 | ||||
71 | KGKNVLINKD | 7/12 | 71 | KGKNVLINKD | 10/14 | |
P | 97 | LPPKKIKDPD | 7/12 | |||
99 | KIKDPDASKP | 8/14 | ||||
107 | AKIDDPTDSK | 7/12 | ||||
C | 156 | QVKSGTIFDN | 10/14 | |||
157 | KSGTIFDNFL | 12/14 | ||||
159 | IFDNFLITND | 8/12 | 159 | IFDNFLITND | 12/14 | |
170 | GVTKAAEKQM | 11/12 | ||||
171 | TKAAEKQMKD | 10/12 | ||||
172 | AAEKQMKDKQ | 7/12 | ||||
173 | EKQMKDKQDE | 9/12 | ||||
176 | KQDEEQRLKE | 8/12 | ||||
178 | EQRLKEEEED | 9/12 | 178 | EQRLKEEEED | 10/14 | |
179 | RLKEEEEDKK | 8/12 | 179 | RLKEEEEDKK | 8/14 | |
180 | KEEEEDKKRK | 10/12 | ||||
181 | EEEDKKRKEE | 9/12 | 181 | EEEDKKRKEE | 8/14 | |
182 | EDKKRKEEEE | 10/12 | 182 | EDKKRKEEEE | 9/14 | |
184 | RKEEEEAEDK | 9/12 | ||||
185 | EEEEAEDKED | 9/12 | 185 | EEEEAEDKED | 10/14 | |
186 | EEAEDKEDDA | 9/12 | 186 | EEAEDKEDDA | 8/14 | |
187 | AEDKEDDAED | 9/12 | ||||
189 | EDDAEDKDED | 7/12 | ||||
190 | DAEDKDEDEE | 8/12 | ||||
191 | EDKDEDEEDE | 7/12 | ||||
192 | KDEDEEDEED | 7/12 | ||||
193 | EDEEDEEDKE | 7/12 | ||||
194 | EEDEEDKEED | 7/12 | 194 | EEDEEDKEED | 8/14 | |
195 | DEEDKEEDEE | 7/12 | ||||
196 | EDKEEDEEED | 7/12 |
No, decapeptide number;
ratio of patients reacting positively with peptides/the number of patients in the group.